Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer

著者: Philippe Rougier, Hanno Riess, Robert Manges, Petr Karásek, Yves Humblet, C. Barone, Armando Santoro, Sylvie Assadourian, Laurence Hatteville, Philip A. Philip - European Journal of Cancer 2013 被引用: 180